A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®

Clinical trial NCT02028312 · WITHDRAWN

Trial details

NCT number

NCT02028312

Sponsor

Edward Holland, MD

Status

WITHDRAWN

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2014-01-01

Primary completion

2016-02-01

Enrollment

0

View on ClinicalTrials.gov